Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study
Chronic Kidney Disease Guideline Adherence - a Cluster Randomized Controlled Quality Improvement Study
1 other identifier
interventional
781
1 country
1
Brief Summary
Chronic kidney disease (CKD) is defined as kidney damage for greater than 3 months or a glomerular filtration rate less than 60 mL/min per 1.73m2 for greater than 3 months. Patients with CKD are at high risk for development of cardiovascular disease and metabolic complications. Guidelines for the care of patients with CKD have been developed by the National Kidney Foundation. Despite the wide availability of these guidelines, adherence is low. The goal of the current study is to evaluate whether a multifactorial intervention, including a CKD registry, will improve CKD guideline adherence. The hypothesis is that providers exposed to a multifactorial clinical intervention including education, academic detailing, and a CKD registry will be more likely to adhere to CKD guidelines than those only exposed to education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2009
CompletedFirst Posted
Study publicly available on registry
June 16, 2009
CompletedStudy Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedResults Posted
Study results publicly available
May 23, 2013
CompletedMay 27, 2013
May 1, 2013
11 months
June 15, 2009
July 30, 2012
May 22, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
PTH (Parathyroid Hormone) Adherence
Probability for having a PTH measured during the study period comparing intervention vs control clinic during the study period as estimated by Generalized Estimating Equation (determines probability, not proportion). Participants assigned 1 if PTH was measured and 0 if PTH was not measured during the study period.
One year
Secondary Outcomes (1)
Last Clinic BP <130/80 mmHg
One year
Study Arms (2)
Multifactorial intervention
EXPERIMENTALThe multifactorial intervention will consist of a CKD lecture, the CKD reference card, academic detailing, and access to the CKD registry.
Education only
ACTIVE COMPARATORProviders in the education only arm will receive a CKD lecture and be given a CKD reference card.
Interventions
The education will consist of a lecture and distribution of a CKD reference card.
Providers in the intervention group will receive a lecture on CKD, a CKD reference card, academic detailing (residents only), and access to the CKD registry.
Eligibility Criteria
You may qualify if:
- All primary care providers at the Wade Park Veterans Affairs Medical Center (VAMC) will be eligible for the study
- Patients:
- Receive primary care from a provider at the Wade Park VAMC
- Have:
- CKD as defined by an estimated glomerular filtration rate (eGFR) less than 60 on two separate occasions 90 to 730 days apart,
- diabetes, OR
- hypertension
You may not qualify if:
- End-stage renal disease
- Renal transplant recipients
- Less than 18 years of age on July 1, 2009
- No primary care visit between Jan 1, 2008 and July 1, 2009
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Louis Stokes Cleveland Veterans Affairs Medical Center
Cleveland, Ohio, United States
Related Publications (5)
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266. No abstract available.
PMID: 11904577BACKGROUNDHoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W. Adherence to K/DOQI practice guidelines for bone metabolism and disease. Am J Manag Care. 2007 Nov;13(11):620-5.
PMID: 17988187BACKGROUNDPhilipneri MD, Rocca Rey LA, Schnitzler MA, Abbott KC, Brennan DC, Takemoto SK, Buchanan PM, Burroughs TE, Willoughby LM, Lentine KL. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol. 2008 Feb;12(1):41-52. doi: 10.1007/s10157-007-0016-3. Epub 2008 Jan 5.
PMID: 18175059BACKGROUNDCabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct 20;282(15):1458-65. doi: 10.1001/jama.282.15.1458.
PMID: 10535437BACKGROUNDDrawz PE, Miller RT, Singh S, Watts B, Kern E. Impact of a chronic kidney disease registry and provider education on guideline adherence--a cluster randomized controlled trial. BMC Med Inform Decis Mak. 2012 Jul 5;12:62. doi: 10.1186/1472-6947-12-62.
PMID: 22765882DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Paul Drawz, MD, MHS, MS
- Organization
- Louis Stokes Cleveland VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Paul E Drawz, MD, MHS, MS
Louis Stokes VA Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Instructor
Study Record Dates
First Submitted
June 15, 2009
First Posted
June 16, 2009
Study Start
July 1, 2009
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
May 27, 2013
Results First Posted
May 23, 2013
Record last verified: 2013-05